- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Growth Potential Companies
Global Pharmaceuticals & Biotech High Growth Potential Companies
Results
514
Companies with a Future performance score of at least 3, ordered by Future performance score.
514 companies
Ascendis Pharma
Market Cap: US$9.0b
A biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$150.99
7D
7.7%
1Y
4.0%
Ascelia Pharma
Market Cap: SEK 263.3m
A biotech company, focuses on orphan oncology treatments in Sweden.
ACE
SEK 2.74
7D
11.6%
1Y
-77.2%
TG Therapeutics
Market Cap: US$5.3b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$36.71
7D
-1.4%
1Y
160.9%
Alnylam Pharmaceuticals
Market Cap: US$30.8b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$237.77
7D
2.1%
1Y
61.0%
Pharma Mar
Market Cap: €1.3b
A biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€73.60
7D
1.5%
1Y
171.6%
Travere Therapeutics
Market Cap: US$1.3b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$14.50
7D
-4.4%
1Y
129.4%
Zevra Therapeutics
Market Cap: US$373.4m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$6.90
7D
-2.1%
1Y
44.2%
Axsome Therapeutics
Market Cap: US$4.8b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$98.06
7D
-0.4%
1Y
43.8%
AVITA Medical
Market Cap: US$227.9m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$8.62
7D
11.1%
1Y
-8.9%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥11.3b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥16.62
7D
5.7%
1Y
27.0%
Guizhou Sanli PharmaceuticalLtd
Market Cap: CN¥5.0b
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products.
603439
CN¥12.51
7D
5.3%
1Y
-14.6%
Jianmin Pharmaceutical GroupLtd
Market Cap: CN¥7.2b
Manufactures and sells medicines in China.
600976
CN¥45.89
7D
3.8%
1Y
-17.8%
PharmaResearch
Market Cap: ₩3.8t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩366,000.00
7D
9.1%
1Y
187.5%
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩31,700.00
7D
7.5%
1Y
11.8%
Arcutis Biotherapeutics
Market Cap: US$1.5b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$12.59
7D
-12.0%
1Y
24.8%
Camurus
Market Cap: SEK 31.9b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.
CAMX
SEK 544.00
7D
4.6%
1Y
11.4%
Chongqing Taiji Industry(Group)Ltd
Market Cap: CN¥12.1b
Develops, produces, and sells traditional Chinese and modern medicine products in China and internationally.
600129
CN¥21.78
7D
9.1%
1Y
-34.1%
Corline Biomedical
Market Cap: SEK 211.6m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.
CLBIO
SEK 8.64
7D
-0.7%
1Y
-25.2%
Elicera Therapeutics
Market Cap: SEK 148.5m
A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.
ELIC
SEK 3.06
7D
-1.3%
1Y
164.9%
RemeGen
Market Cap: HK$22.7b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$28.60
7D
7.9%
1Y
-11.3%
ALTEOGEN
Market Cap: ₩20.0t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩374,500.00
7D
3.2%
1Y
109.6%
Xbrane Biopharma
Market Cap: SEK 301.8m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.20
7D
7.8%
1Y
-45.0%
Bonesupport Holding
Market Cap: SEK 19.2b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 291.60
7D
-1.6%
1Y
20.9%
Devyser Diagnostics
Market Cap: SEK 1.4b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 87.00
7D
-5.3%
1Y
-16.3%
Acrux
Market Cap: AU$9.8m
Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.
ACR
AU$0.023
7D
-8.0%
1Y
-62.3%
PharmaEssentia
Market Cap: NT$164.9b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$497.00
7D
3.0%
1Y
58.3%
Blue Jet Healthcare
Market Cap: ₹118.6b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹683.55
7D
4.2%
1Y
77.2%
ABL Bio
Market Cap: ₩2.7t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩62,200.00
7D
40.6%
1Y
179.6%
Beijing Wantai Biological Pharmacy Enterprise
Market Cap: CN¥85.8b
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
CN¥67.82
7D
4.3%
1Y
-12.1%
Akeso
Market Cap: HK$73.8b
A biopharmaceutical company, researches, develops, manufactures, and commercializes antibody drugs.
9926
HK$82.20
7D
-4.3%
1Y
66.1%
Neuland Laboratories
Market Cap: ₹150.2b
Manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹11,705.40
7D
2.2%
1Y
75.7%
BioArctic
Market Cap: SEK 14.6b
Develops biological drugs for patients with disorders of the central nervous system in Sweden.
BIOA B
SEK 164.60
7D
-0.06%
1Y
-18.7%
Botanix Pharmaceuticals
Market Cap: AU$650.6m
Engages in the research and development of dermatology and antimicrobial products in Australia and the United States.
BOT
AU$0.35
7D
-11.3%
1Y
73.2%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥11.0b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥50.26
7D
4.9%
1Y
-2.9%
Cosmo Pharmaceuticals
Market Cap: CHF 741.5m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 46.30
7D
-1.9%
1Y
-33.8%
Sernova Biotherapeutics
Market Cap: CA$55.8m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.17
7D
0%
1Y
-63.8%